Key result
Atrial septal defect closure with the Figulla septal occluder resulted in significantly lower postprocedural P-wave dispersion compared to the Amplatzer septal occluder (44.1 vs 50.1 msec; p<0.001).
Why the study?
Does the Figulla septal occluder compared to the Amplatzer septal occluder reduce P-wave duration and dispersion in patients undergoing percutaneous closure of secundum ASD?
Cohort (n=121)
Does the Figulla septal occluder compared to the Amplatzer septal occluder reduce P-wave duration and dispersion in patients undergoing percutaneous closure of secundum ASD?
Absolute Event Rate: 44.1% vs 50.1%
p-value: p=<0.001
Percutaneous ASD closure increases P-wave duration and dispersion immediately post-procedure, but the Figulla septal occluder results in significantly lower P-wave dispersion compared to the Amplatzer septal occluder, without apparent differences in clinical arrhythmias.
Findings on P-wave parameters after FSO versus ASO ASD closure are hypothesis-generating; prospective trials needed before clinical consideration.
OBJECTIVE: Amplatzer septal occluder (ASO) is the most widely used device for closure of atrial septal defect (ASD). Figulla septal occluder (FSO) is a similar device to ASO with some structural innovations. The aim of study is to assess the maximum P-wave duration (Pmax) and dispersion (Pd) in patients who underwent ASD closure with both devices, to determine the effects of structural innovations on atrial electrical inhomogeneity. METHODS: The study is a retrospective cohort analysis. Between December 2005 and March 2010, 121 patients underwent percutaneous closure of secundum ASD were included in this study. FSO was used in 79 patients, ASO in 42 patients. Pmax and Pd were measured on the surface electrocardiography before and soon after procedure. For comparison of P-wave parameters initially and after procedure paired t-test was used. Correlation analysis was performed using Pearson correlation test. RESULTS: Pmax and Pd were significantly increased immediate after procedure (p<0.001). In FSO and ASO group pre/postprocedural Pd were 38.3 ± 2.7/ 44.1 ± 2.7 msec and 37.5 ± 2.5/ 50.1 ± 2.2 msec respectively. ASO group had a greater postprocedural Pmax and Pd (p<0.001). Left and right atrial disc diameter and device size were the strongest correlates of Pd (r=0.52, p<0.001; r=0.58, p<0.001; r=0.35, p=0.001, respectively). Moderate correlation was found between pre-intervention Pd and age (p=0.008). CONCLUSIONS: Pmax and Pd were significantly increased soon after atrial septal defect closure procedure in both devices. Pd is significantly lower in patients closed with FSO device. Difference may be due to the distinctive texture of devices. There was no significant difference in terms of clinically apparent arrhythmia after closure with both device types.
No takes yet. Share an insight, caveat, or question.
Paç et al. (2012) conducted a cohort in Atrial septal defect (ASD) (n=121). Figulla septal occluder (FSO) vs. Amplatzer septal occluder (ASO) was evaluated on Postprocedural P-wave dispersion (Pd) (p=<0.001). Atrial septal defect closure with the Figulla septal occluder resulted in significantly lower postprocedural P-wave dispersion compared to the Amplatzer septal occluder (44.1 vs 50.1 msec; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: